biomedical research

See the following -

Pistoia Alliance Driving Open Innovation in Bioresearch

The Pistoia Alliance recently held its 4th Annual Conference at the Marriott Marquis in New York City. As part of the Next Chapter Initiative this was widened to a three-day event to include a special members-only meeting on the second day, kindly hosted by Thomson Reuters at their headquarters in Times Square, and a face-to-face board meeting hosted by Roche at the Alexandria Centre. Read More »

Pistoia Alliance Wins Bio-IT World Grand Prize-Continues Innovation Mission

I received an email newsletter this morning from the Pistoia Alliance and it was so full of information and updates that I decided to post the entire newsletter as an article. A note on the Pistoia Alliance is long overdue. I had meant to write an article on the Alliance back in April after the 2014 Bio-IT World conference organizers announced that Pistoia's HELM project had been chosen as one of the Grand prize winners. Read More »

Shutdown Imperils Costly Lab Mice, Years Of Research

Jon Hamilton | NPR | October 10, 2013

The government shutdown is likely to mean an early death for thousands of mice used in research on diseases such as diabetes, cancer and Alzheimer's. Read More »

SMART On The Agenda At AMIA 2012

Staff Writer | SMART Platforms | November 3, 2012

The AMIA 2012 Annual Symposium begins today in Chicago, where it is currently “Informatics Week” as declared by Mayor Rahm Emanuel. Read More »

The $100,000-Per-Year Pill: How US Health Agencies Choose Pharma Over Patients

Fran Quigley | TruthOut | August 5, 2016

Don Reichmuth survived prostate cancer once before, back in 2007, so his physician was concerned when tests recently revealed the cancer had returned. Reichmuth's physician prescribed a drug called enzalutamide, marketed by the Japanese company Astellas Pharma, Inc. under the brand name Xtandi. But when the physician sent the prescription to the pharmacy, the managers of Reichmuth's insurance plan sent back an immediate refusal to approve it. Reichmuth, a retired teacher who lives in Washington State, was puzzled by the logic. Then he learned the price of the Xtandi prescription: over $9,700 each month...

Read More »

The Doctor Is In

Mark Mitchell | Government Executive | July 1, 2013

I’m a little underslept today,” Dr. Francis Collins laughs, sitting in his office in the historic Building 1 of the National Institutes of Health’s sprawling campus in Bethesda, Md., where he presides as the dean of the nation’s health. [...] Read More »

Toolkit Designed To Make Biomedical Data Exploration Easier

Susan D. Hall | FierceHealthIT | October 18, 2013

Researchers have developed an open-source platform for creating software applications that make complex data understandable and accessible to those without sophisticated informatics expertise. Read More »

Winners And Losers With The 21st Century Cures Bill

Sydney Lupkin and Steven Findlay | NPR | December 2, 2016

A sprawling health bill that passed the Senate Thursday by a 94 to 5 vote and is expected to gain President Obama's signature is a grab bag for industries, academic institutions and patient groups that spent oodles of time and money lobbying to advance their interests. Senate Majority Leader Mitch McConnell calls it "the most important legislation that Congress will pass this year." Who wins and who loses? Here's the rundown of what's at stake in the 21st Century Cures Act...

Read More »

Winners Announced for Crowdsourcing and Data Sharing Competition to Drive Innovation in Prostate Cancer Research

Press Release | Sage Bionetworks, Project Data Sphere Initiative, DREAM Challenges Initiative | August 27, 2015

Industry leaders in biomedical research, oncology data sharing and computational science announced the winners of an innovative research challenge for prostate cancer using previously unavailable clinical data. The Prostate Cancer DREAM Challenge is the first research challenge in prostate cancer to marry crowdsourcing with data sharing, paving a new way to tackle key research questions about metastatic castration-resistant prostate cancer (mCRPC), an advanced form of the disease with poor outcomes. The Challenge called upon the cancer research and computational biology community to find solutions to key open clinical research questions about mCRPC and explore innovative research and modeling approaches. The three specific questions posed were to:

Bio-IT World Conference & Expo 2017

Event Details
Type: 
Conference
Date: 
May 23, 2017 (All day) - May 25, 2017 (All day)
Location: 
Seaport World Trade Center Boston, MA
United States

The Bio-IT World Conference & Expo is a conference designed to showcase a wide variety of IT and informatics applications and enabling technologies for biomedical research, clinical and healthcare initiatives, and drug discovery and development. More than 3,300 delegates representing 41 countries are expected to attend this three-day event. The 2017 conference features more than 280 speakers, keynotes, workshops, industry awards, an exhibit hall, and the FAIR Data Hackathon 2017...

Read More »